Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: Is this drug active against acute myelogenous leukemia?
Y. Takemura et al., Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: Is this drug active against acute myelogenous leukemia?, INT J HEMAT, 72(1), 2000, pp. 112-114